Patient-derived organoids: Transforming cancer research and personalized medicine

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment through advanced 3D modeling techniques.

Thermo Fisher is ready to expand its viral vector production site in Massachusetts once there’s ‘demand for it’

PLAINVILLE, Mass. — Just a year after opening its $180 million viral vector manufacturing site in Massachusetts, Thermo Fisher already has expansion on its mind.

September 20, 2023

John Carroll on his cancer diagnosis; #ESMO’s biggest surprise; Lykos’ bad trip; Rate cuts, and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 22, 2024

TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology

Social media site TikTok has become a common source of misinformation about gynecologic cancers. (Ohio State University Comprehensive Cancer Center, Gynecologic Oncology) PGA Tour golfer

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.